Opportunistic Infections Citation List:
October 14, 2009 -October 27, 2009
1. Pfaller MA, Diekema DJ, Messer SA, Hollis RJ, Jones RN. In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole- resistant isolates.
Antimicrob Agents Chemother 2003;47: 1068-71.
DOI 10.1128/AAC.47.3.1068-1071.2003
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
2. Mao, J., H. Yuan, Y. Wang, B. Wan, M. Pieroni, Q. Huang, R.B. van Breemen, A.P. Kozikowski, and S.G. Franzblau, From Serendipity to Rational Antituberculosis Drug Discovery of Mefloquine-Isoxazole Carboxylic Acid Esters. J Med Chem, 2009; PMID[19863050] http://www.ncbi.nlm.nih.gov/pubmed/19863050?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=17
3. Nilsson, M.T., W.W. Krajewski, S. Yellagunda, S. Prabhumurthy, G.N. Chamarahally, C. Siddamadappa, B.R. Srinivasa, S. Yahiaoui, M. Larhed, A. Karlen, T.A. Jones, and S.L. Mowbray, Structural basis for the inhibition of Mycobacterium tuberculosis glutamine synthetase by novel ATP-competitive inhibitors. J Mol Biol, 2009. 393(2): p. 504-13; PMID[19695264] http://www.ncbi.nlm.nih.gov/pubmed/19695264?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=157
4. Pieroni, M., A. Lilienkampf, B. Wan, Y. Wang, S.G. Franzblau, and A.P. Kozikowski, Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes. J Med Chem, 2009. 52(20): p. 6287-96; PMID[19757815] http://www.ncbi.nlm.nih.gov/pubmed/19757815?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=148
5. Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis.
Horita Y, Takii T, Chiba T, Kuroishi R, Maeda Y, Kurono Y, Inagaki E, Nishimura K, Yamamoto Y, Abe C, Mori M, Onozaki K.
Bioorg Med Chem Lett. 2009 Nov 15;19(22):6313-6. Epub 2009 Sep 27.
PMID: 19828313 [PubMed - in process]
6. Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives.
Candéa AL, Ferreira Mde L, Pais KC, Cardoso LN, Kaiser CR, Henriques MG, Lourenço MC, Bezerra FA, de Souza MV.
Bioorg Med Chem Lett. 2009 Nov 15;19(22):6272-4. Epub 2009 Sep 29.
PMID: 19819134 [PubMed - in process]
7. Phosphorus-nitrogen compounds. 18. Syntheses, stereogenic properties, structural and electrochemical investigations, biological activities, and DNA interactions of new spirocyclic mono- and bisferrocenylphosphazene derivatives.
Asmafiliz N, Kiliç Z, Oztürk A, Hökelek T, Koç LY, Açik L, Kisa O, Albay A, Ustündağ Z, Solak AO.
Inorg Chem. 2009 Nov 2;48(21):10102-16.
PMID: 19813722 [PubMed - in process]
8. Defining the mode of action of tetramic acid antibacterials derived from Pseudomonas aeruginosa quorum sensing signals.
Lowery CA, Park J, Gloeckner C, Meijler MM, Mueller RS, Boshoff HI, Ulrich RL, Barry CE 3rd, Bartlett DH, Kravchenko VV, Kaufmann GF, Janda KD.
J Am Chem Soc. 2009 Oct 14;131(40):14473-9.
PMID: 19807189 [PubMed - in process]
9. Gupta, R.K., T.S. Thakur, G.R. Desiraju, and J.S. Tyagi, Structure-based design of DevR inhibitor active against nonreplicating Mycobacterium tuberculosis. J Med Chem, 2009. 52(20): p. 6324-34; PMID[19827833] http://www.ncbi.nlm.nih.gov/pubmed/19827833?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=136.
10. Fyfe, P.K., V.A. Rao, A. Zemla, S. Cameron, and W.N. Hunter, Specificity and Mechanism of Acinetobacter baumanii Nicotinamidase: Implications for Activation of the Front-Line Tuberculosis Drug Pyrazinamide. Angew Chem Int Ed Engl, 2009; PMID[19859929] http://www.ncbi.nlm.nih.gov/pubmed/19859929?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=25.
11. Connell, N.D. and V. Venketaraman, Control of Mycobacterium Tuberculosis Infection by Glutathione. Recent Pat Antiinfect Drug Discov, 2009; PMID[19832692] http://www.ncbi.nlm.nih.gov/pubmed/19832692?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=131.
Citations from the ISI Web of Knowledge Listings for O.I.
12. Samota, MK, et al.
Synthesis, Characterization, and Biological Activity of Organophosphates Derived from Substituted Benzoxazole
HETEROATOM CHEMISTRY 2009 20: 309 - 315
13. Arai, M., et al.
Haliclonacyclamines, Tetracyclic Alkylpiperidine Alkaloids, as Anti-dormant Mycobacterial Substances from a Marine Sponge of Haliclona sp.
CHEMICAL & PHARMACEUTICAL BULLETIN 2009 (Oct.) 57: 1136 - 1138
14. Balamurugan, K, et al.
A facile domino protocol for the regioselective synthesis and discovery of novel 2-amino-5-arylthieno-[2,3-b]thiophenes as antimycobacterial agents
TETRAHEDRON LETTERS 2009 50: 6191 - 6195
15. Junior, COR, et al.
Preparation and antitubercular activity of lipophilic diamines and amino alcohols
MEMORIAS DO INSTITUTO OSWALDO CRUZ 2009 (August) 104: 703 - 705
16. Zhang, XL, et al.
Synthesis and evaluation of (S,S)-N,N '-bis-[3-(2,2 ',6,6 '-tetramethylbenzhydryloxy)-2-hydroxy-propyl]-ethylenediamine (S2824) analogs with anti-tuberculosis activity
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2009 (Nov.) 19: 6074 - 6077